Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Duha M. Al-Shorafat"'
Autor:
Leonie F. Becker, Sinem Tunc, Peter Murphy, Tobias Bäumer, Anne Weissbach, Martje G. Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony E. Lang, Christian Beste, Tobias H. Donner, Julius Verrel, Alexander Münchau
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Dopa-responsive dystonia (DRD) is caused by an impaired dopamine biosynthesis due to a GTP-cyclohydrolase-1 (GCH1) deficiency, resulting in a combination of dystonia and parkinsonism. However, the effect of GCH1 mutations and levodopa treatm
Externí odkaz:
https://doaj.org/article/06c8a7b3c4a44af0832037c6d5c69403
Autor:
Anne Weissbach, Annika Steinmeier, Martje Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony Lang, Norbert Brüggemann, Vera Tadic, Christine Klein, Alexander Münchau, Tobias Bäumer, Matt J.N. Brown
Publikováno v:
Parkinsonism & Related Disorders. 95:40-46
GCH1 mutations have been linked to decreased striatal dopamine and development of dopa-responsive dystonia (DRD) and Parkinsonism. Sensory and sensorimotor integration impairments have been documented in various forms of dystonia. DRD patients with c
Publikováno v:
Journal of Blood Medicine.
Mahmoud H Ayesh Haj Yousef,1 Ziad Audat,2 Duha M Al-Shorafat,3 Sohaib Al-Khatib,4 Ammar K Daoud1 1Department of Internal Medicine, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan; 2De
Autor:
Leonie F. Becker, Sinem Tunc, Peter Murphy, Tobias Bäumer, Anne Weissbach, Martje G. Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony E. Lang, Christian Beste, Tobias H. Donner, Julius Verrel, Alexander Münchau
Publikováno v:
Scientific reports. 12(1)
Dopa-responsive dystonia (DRD) is caused by an impaired dopamine biosynthesis due to a GTP-cyclohydrolase-1 (GCH1) deficiency, resulting in a combination of dystonia and parkinsonism. However, the effect of GCH1 mutations and levodopa treatment on mo
Publikováno v:
Neurodegenerative Disease Management. 9:135-147
Treatment strategies for dystonia depend on the focal, segmental or generalized distribution of symptoms. Chemodenervation with botulinum toxin remains the treatment of choice for focal- or select-body regions in generalized and segmental dystonia. A
Publikováno v:
Mov Disord Clin Pract
Background Although the β-blocker propranolol is considered one of the most effective tremor treatments and other β-blockers are often prescribed to patients with tremor, those with partial β-agonist activity on β-adrenoreceptors can theoreticall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9797d3d75af4971d54341680617c436
https://europepmc.org/articles/PMC8015902/
https://europepmc.org/articles/PMC8015902/